date,title,source
Oct-17-18,Stocks Jump 2%+ on Solid Earnings,Zacks
Oct-19-18,Phase 2 GEOMETRY mono-1 Trial of Investigational Medicine Capmatinib Shows Positive Results in Patients with MET-mutated Advanced NSCLC,Business Wire
Oct-24-18,Incyte (INCY) to Report Q3 Earnings: What's in the Cards?,Zacks
Oct-24-18,"Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod",Zacks
Oct-25-18,Incyte Named a 2018 Top Employer by Science Magazine,Business Wire
Oct-30-18,Incyte Corp (INCY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-30-18,"Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View",Zacks
Oct-30-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-30-18,Incyte (INCY) Misses Q3 Earnings and Revenue Estimates,Zacks
Oct-30-18,Incyte: 3Q Earnings Snapshot,Associated Press
Oct-30-18,Incyte Reports 2018 Third Quarter and Nine Month Financial Results and Provides Updates on Key Clinical Programs,Business Wire
Oct-31-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,"Scary Markets, Frightening Stocks, and How to Keep From Panicking",Motley Fool
Nov-01-18,Edited Transcript of INCY earnings conference call or presentation 30-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Multiple Abstracts Highlighting Data from Incytes Targeted Therapy Portfolio Accepted for Presentation at the 60th Annual ASH Meeting,Business Wire
Nov-01-18,"3 Big Stock Charts for Thursday: Walmart, Prologis and Incyte",InvestorPlace
Nov-01-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Incyte,ACCESSWIRE
Nov-05-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Molson Coors Brewing, Coca-Cola European Partners, Brinker International, Incyte, RPC, and Group 1 Automotive  New Research Emphasizes Economic Growth",GlobeNewswire
Nov-07-18,Incyte to Present at Upcoming Investor Conference,Business Wire
Nov-15-18,Merck's Keytruda Improves Survival in Esophageal Cancer Study,Zacks
Nov-19-18,"AstraZeneca's Imfinzi Fails in Lung Cancer Study, Stock Down",Zacks
Nov-21-18,This Highly Rated Pharma Giant Is More Than Just A Diabetes Player,Investor's Business Daily
Nov-23-18,A Look At The Intrinsic Value Of Incyte Corporation (NASDAQ:INCY),Simply Wall St.
Nov-27-18,Incyte Appoints Dr. Dashyant Dhanak as Chief Scientific Officer,Business Wire
Nov-29-18,Why Is Incyte (INCY) Up 1.5% Since Last Earnings Report?,Zacks
Dec-04-18,Incyte (INCY) Announces Positive Data on Jakafi for GVHD,Zacks
Dec-04-18,Today's Research Reports on Trending Tickers: Incyte and Supernus Pharmaceuticals,ACCESSWIRE
Dec-06-18,"Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger",Zacks
Dec-10-18,Why MacroGenics Stock Is Getting Hammered Today,Motley Fool
Dec-10-18,5 Top Drug/Biotech Merger & Acquisition Targets for 2019,Zacks
Dec-12-18,Roche to Create Companion Diagnostic Test for Merck's Keytruda,Zacks
Dec-13-18,Top 10 Healthcare Stories of 2018,Motley Fool
Dec-13-18,Incyte to Present at Upcoming Investor Conferences,Business Wire
Dec-13-18,FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE),PR Newswire
Dec-14-18,5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride,Zacks
Dec-17-18,Incyte (INCY) Collaborates with Innovent for 3 Candidates,Zacks
Dec-17-18,Incyte enters into potential $391M collaboration with Chinese biopharm firm,American City Business Journals
Dec-18-18,Here Are Biotechs Big Pipeline Disappointments in 2018,Motley Fool
Dec-18-18,Immuno-Oncology Suffered a Setback in 2018. Whats Next?,Motley Fool
Dec-19-18,"Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY",Zacks
Dec-20-18,Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program for Ruxolitinib Cream in Atopic Dermatitis,Business Wire
Dec-20-18,"The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte",Zacks
Dec-21-18,Merck's sBLA for Keytruda in Lung Cancer Gets Extended Review,Zacks
Jan-03-19,Factbox - Bristol-Myers' $74 billion Celgene buy has investors looking for next deal,Reuters
Jan-03-19,"Why Celgene, Agenus, and Incyte Jumped Today",Motley Fool
Jan-03-19,Incyte Climbs on Guggenheim Upgrade,TheStreet.com
Jan-03-19,Incyte Appoints Christiana Stamoulis as Chief Financial Officer,Business Wire
Jan-04-19,"3 Big Stock Charts for Friday: Incyte, Schlumberger and Abbott Laboratories",InvestorPlace
Jan-04-19,"Merck Buys NASH Candidate, Keytruda Wins 5 Approvals in Japan",Zacks
Jan-07-19,Why Agenus Stock Is Spiking Today,Motley Fool
Jan-07-19,Merus Announces IND Clearance for MCLA-145,GlobeNewswire
Jan-08-19,4 Biotechs That Are Potential Buyouts Post Celgene Deal,Zacks
Jan-11-19,3 Biotech Stocks Bubbling Away,Investopedia
Jan-14-19,What's in Store for Merck in 2019 After a Solid Run in '18?,Zacks
Jan-15-19,Heres your guide to the upcoming biotechnology takeover wave,MarketWatch
Jan-15-19,Why Yet Another Biotech Stock Is Grabbing Renewed Takeover Chatter,Investor's Business Daily
Jan-15-19,"FANG Stocks, Cyclicals Lead Nasdaq, Dow Jones Up; This Sector Is Poised To Rally More",Investor's Business Daily
Jan-16-19,Today's Research Reports on Trending Tickers: Incyte and CorMedix,ACCESSWIRE
Jan-22-19,Should You Take Comfort From Insider Transactions At Incyte Corporation (NASDAQ:INCY)?,Simply Wall St.
Jan-22-19,Incyte Announces First Patient Treated in Phase 3 Clinical Trial of Itacitinib for Chronic Graft-Versus-Host Disease,Business Wire
Jan-23-19,"Biotech Stock Roundup: Amgen, Vertex Get EC Nod for Label Expansion of Drugs",Zacks
Jan-24-19,Incyte to Report Fourth Quarter and Year-end Financial Results,Business Wire
Jan-25-19,Moving Average Can Give Early Signals Of Trouble,Investor's Business Daily
Jan-25-19,4 Toxic Stocks to Get Rid Off or Sell Short for Solid Gains,Zacks
Jan-28-19,"Zacks.com featured highlights include: Incyte, KEYW, First Majestic and Mattel",Zacks
Jan-28-19,Today's Research Reports on Trending Tickers: Incyte and Repligen,ACCESSWIRE
Jan-28-19,"3 Big Stock Charts for Monday: Pfizer, MGM Resorts and Incyte",InvestorPlace
Jan-29-19,"Report: Developing Opportunities within Incyte, Burlington Stores, Hannon Armstrong Sustainable Infrastructure Capital, iRobot, Lear, and Menlo Therapeutics  Future Expectations, Projections Moving into 2019",GlobeNewswire
Jan-30-19,Dow Pushes Forward Under Apple's Shadow,Zacks
Feb-04-19,Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis,PR Newswire
Feb-05-19,Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies,Zacks
Feb-06-19,MacroGenics stock spikes from positive results of cancer drug trial,American City Business Journals
Feb-07-19,FDA Delays This Biotech's Drug  Why Analysts Are Still Bullish,Investor's Business Daily
Feb-07-19,FDA resets decision date on Incyte's GVHD treatment application,American City Business Journals
Feb-08-19,Incyte Down as FDA Extends Review Period of Jakafi for GVHD,Zacks
Feb-11-19,Is a Disappointment in Store for Incyte (INCY) Q4 Earnings?,Zacks
Feb-11-19,4 Toxic Stocks to Abandon or Sell Short for Solid Gains,Zacks
Feb-11-19,Why Incyte Stock Gained 27% in January,Motley Fool
Feb-12-19,"Zacks.com featured highlights include: Incyte, First Majestic, Mattel and U.S. Silica",Zacks
Feb-12-19,Merck's Keytruda Gets FDA Priority Review for Head/Neck Cancer,Zacks
Feb-13-19,Incyte Expected to Earn 17 Cents a Share,TheStreet.com
Feb-13-19,"Biotech Stock Roundup: Regeneron Impresses in Q4, Gilead Slumps, MacroGenics Soars",Zacks
Feb-14-19,Incyte (INCY) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-14-19,Highly Rated Biotech Turns Profitable  But Earnings Lag Estimates,Investor's Business Daily
Feb-14-19,"Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat",Zacks
Feb-19-19,Merck's (MRK) Stock Up Almost 50% in a Year: Here's Why,Zacks
Feb-19-19,Incyte to Present at Upcoming Investor Conferences,Business Wire
Feb-20-19,6 Companies With 20% Or More Earnings Growth,Investopedia
Feb-20-19,Merck's Keytruda Fails to Meet Endpoint in Liver Cancer Study,Zacks
Feb-21-19,Looking For Growth? Take A Look At These Biotechnology Stocks,Investor's Business Daily
Feb-21-19,Merck Gets Priority Review for Keytruda in Third-Line SCLC,Zacks
Feb-26-19,4 Toxic Stocks to Discard or Sell Short for Solid Gains,Zacks
Feb-27-19,"Zacks.com featured expert Kevin Matras highlights: First Majestic Silver, Incyte, Covanta and U.S. Silica",Zacks
Feb-27-19,"3 Big Stock Charts for Wednesday: Cabot Oil & Gas, Incyte and Sempra Energy",InvestorPlace
Feb-27-19,Macrogenics Inc (MGNX) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-28-19,Incyte Joins Patient Organizations Worldwide in Recognizing Rare Disease Day 2019,Business Wire
Feb-28-19,Data from Incytes Cancer Research Portfolio to be Featured in Seven Abstracts at the AACR Annual Meeting 2019,Business Wire
Mar-01-19,"New Research Coverage Highlights Nasdaq, Constellation Brands, Incyte, IMAX, HNI, and Frank's International N.V  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Mar-05-19,Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda,Zacks
Mar-05-19,Incyte- Insights into Small Molecule Drugs,MoneyShow
Mar-06-19,"More biotech takeover targets coming, says Jefferies top analyst",CNBC Videos
Mar-06-19,Pullback Strategies: 10 Stocks That Could Fall the Fastest,Investopedia
Mar-08-19,Why Incyte Corporation (NASDAQ:INCY) Is A Financially Healthy Company,Simply Wall St.
Mar-13-19,10 Stocks Powering S&amp;P 500 ETF in the 10-Year Bull Run,Zacks
Mar-13-19,4 Toxic Stocks to Abandon or Sell Short for Solid Gains,Zacks
Mar-14-19,Agenus Inc (AGEN) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-14-19,"Zacks.com featured expert Kevin Matras highlights: Incyte, AMC Entertainment, Covanta and U.S. Silica",Zacks
Mar-21-19,Looking For Growth? Take A Look At These Biotechnology Stocks,Investor's Business Daily
Apr-01-19,Did Hedge Funds Drop The Ball On Incyte Corporation (INCY) ?,Insider Monkey
Apr-01-19,Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019,GlobeNewswire
Apr-02-19,BriaCell Announces Clinical Trial Collaboration Agreement with Incyte,GlobeNewswire
Apr-03-19,Puts Active After RBC Downgrades Incyte Stock,Schaeffer's Investment Research
Apr-04-19,Looking For Growth? Take A Look At These Biotechnology Stocks,Investor's Business Daily
Apr-08-19,Concert Pharmaceuticals' stock takes a sharp dive after disappointing patent appeal board ruling,MarketWatch
Apr-11-19,Concert Pharma Initiates Early-Stage Schizophrenia Study,Zacks
Apr-11-19,Incyte to Report First Quarter Financial Results,Business Wire
Apr-12-19,Merck's Keytruda Gets FDA Nod for Expanded Lung Cancer Group,Zacks
Apr-18-19,Health-care drama has now spread to biopharma stocks,MarketWatch
Apr-22-19,Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?,Zacks
Apr-22-19,Is a Beat in Store for AbbVie (ABBV) This Earnings Season?,Zacks
Apr-22-19,Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?,Zacks
Apr-22-19,5 Must-Buy Stocks Amid Exaggerated Economic Slowdown,Zacks
Apr-23-19,Amgen (AMGN) to Report Q1 Earnings: What's in the Cards?,Zacks
Apr-23-19,What's in the Cards for AstraZeneca (AZN) in Q1 Earnings?,Zacks
Apr-23-19,Incyte (INCY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Zacks
Apr-23-19,"The Zacks Analyst Blog Highlights: CommScope, Ceridian HCM, Cabot Oil &amp; Gas, Incyte and Snap",Zacks
Apr-24-19,What's in Store for Vertex (VRTX) This Earnings Season?,Zacks
Apr-24-19,What's in the Cards for Amarin (AMRN) This Earnings Season?,Zacks
Apr-24-19,Trevena (TRVN) to Post Q1 Earnings: What Awaits the Stock?,Zacks
Apr-24-19,"Solid Earnings Boost S&P, NASDAQ to New Closing Highs",Zacks
Apr-24-19,5 Biotech Stocks Defying the Medicare-for-All Scare,Zacks
Apr-24-19,Can S&amp;P 500 and Nasdaq Sustain Record Run? 5 Top Picks,Zacks
Apr-25-19,Exelixis (EXEL) to Report Q1 Earnings: What's in Store?,Zacks
Apr-25-19,"The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences",Zacks
Apr-25-19,"The Zacks Analyst Blog Highlights: CommScope, Incyte, Cigna, Columbia Sportswear and Synopsys",Zacks
Apr-26-19,Will HIV Franchise Sales Drive Gilead's (GILD) Q1 Earnings?,Zacks
Apr-26-19,Is a Beat in Store for Glaxo (GSK) This Earnings Season?,Zacks
Apr-29-19,Incyte Expected to Earn 29 Cents a Share,TheStreet.com
Apr-29-19,Is a Beat in the Cards for Incyte (INCY) in Q1 Earnings?,Zacks
Apr-29-19,Why Novartis Earnings Provided A Bullish Signal For This Biotech Stock,Investor's Business Daily
Apr-29-19,What's in the Cards for Sarepta (SRPT) This Earnings Season?,Zacks
Apr-30-19,Top Biotech Stocks for February 2019,Investopedia
Apr-30-19,Edited Transcript of INCY earnings conference call or presentation 30-Apr-19 12:00pm GMT,Thomson Reuters StreetEvents
Apr-30-19,Incyte Corp (INCY) Q1 2019 Earnings Call Transcript,Motley Fool
Apr-30-19,This Biotech Stock Just Topped Expectations  And Became Profitable,Investor's Business Daily
Apr-30-19,5 Biotech Stocks for a Long-Lived Portfolio,InvestorPlace
Apr-30-19,"Incyte (INCY) Q1 Earnings &amp; Revenues Beat Estimates, Up Y/Y",Zacks
Apr-30-19,Incyte: 1Q Earnings Snapshot,Associated Press
Apr-30-19,Incyte Reports 2019 First Quarter Financial Results and Provides Updates on Key Clinical Programs,Business Wire
Apr-30-19,"Incyte Earnings, Revenue Beat in Q1",Investing.com
May-01-19,"Biotech Stock Roundup: BIIB, VRTX, ALXN Q1 Earnings Top &amp; Other Pipeline Updates",Zacks
May-02-19,Edited Transcript of INCY earnings conference call or presentation 30-Apr-19 12:00pm GMT,Thomson Reuters StreetEvents
May-02-19,"The Zacks Analyst Blog Highlights: Biogen, Celgene, Incyte, Alexion and Vertex",Zacks
May-02-19,Incyte to Present at Upcoming Investor Conferences,Business Wire
May-06-19,Looking For Growth? Take A Look At These Biotechnology Stocks,Investor's Business Daily
May-08-19,Why Incyte Stock Lost 11% in April,Motley Fool
May-09-19,Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors,GlobeNewswire
May-13-19,Here are Mondays worst stock-market performers as U.S.-China trade dispute escalates,MarketWatch
May-13-19,BriaCell Approves New Board of Directors and Chairman at Annual and Special Meeting of Shareholders,GlobeNewswire
May-14-19,Here are Mondays worst stock-market performers as U.S.-China trade dispute escalates,MarketWatch
May-16-19,Incyte Announces Abstracts Accepted for Presentation at the 2019 ASCO Annual Meeting and the 24th Congress of EHA,Business Wire
May-20-19,Why I Like Incyte Corporation (NASDAQ:INCY),Simply Wall St.
May-20-19,Data from Incytes Inflammation and Autoimmunity Portfolio to be Featured at the 24th World Congress of Dermatology,Business Wire
May-21-19,Merck's Keytruda Fails in Late-Stage Breast Cancer Study,Zacks
May-22-19,FDA to rule this week on Incyte's bid for wider use of Jakafi,American City Business Journals
May-23-19,Incyte to Present at Upcoming Investor Conference,Business Wire
May-24-19,Incyte's Jakafi gets FDA approval to treat Graft vs Host Disease,Reuters
May-24-19,"Top Stock Reports for Medtronic, TJX Companies & Deere",Zacks
May-24-19,Incyte's Jakafi wins FDA nod to treat complication of stem cell transplant,Reuters
May-28-19,"The Zacks Analyst Blog Highlights: Medtronic, TJX, Deere, Incyte and Netapp",Zacks
May-28-19,FDA approves Incyte's Jakafi as graft-versus-host disease therapy,American City Business Journals
May-28-19,BriaCells Novel Technology and Clinical Data Published at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting,GlobeNewswire
May-29-19,"Biotech Stock Roundup: AMGN's Nuevolution Buyout, CELG, INCY Drugs' Label Expansion",Zacks
May-30-19,Mesoblast Starts Rolling BLA Submission for Remestemcel-L,Zacks
May-30-19,Why Is Incyte (INCY) Down 1.7% Since Last Earnings Report?,Zacks
Jun-03-19,Novartis (NVS) Announces Various Data Presentations at ASCO,Zacks
Jun-03-19,New Data from GEOMETRY mono-1 Study Show Clinically Meaningful Results in Patients with Non-Small Cell Lung Cancer with MET exon-14 Skipping Mutation Treated with Capmatinib,Business Wire
Jun-04-19,Incyte Announces First Patient Treated in Phase 3 Clinical Trial of Pemigatinib as a First-Line Therapy for Cholangiocarcinoma,Business Wire
Jun-05-19,Celgene (CELG) Presents Data on Pipeline Candidates at ASCO,Zacks
Jun-06-19,Incyte Begins Phase III Study for Treatment of Duct Cancer,Zacks
Jun-07-19,9 interesting things heard during BIO 2019 (Photos),American City Business Journals
Jun-12-19,Merck's Keytruda Wins FDA Nod for First-Line Head/Neck Cancer,Zacks
Jun-13-19,Concert Pharma's CTP-692 Positive for Schizophrenia in Phase I,Zacks
Jun-13-19,Keytruda &amp; 4 Other Reasons to Invest in Merck's (MRK) Stock,Zacks
Jun-13-19,Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study,Zacks
Jun-17-19,Shares of cancer-therapy companies skyrocket after Pfizer acquisition news,MarketWatch
Jun-17-19,2 Rallying Pharma Stocks Roping In Option Bulls,Schaeffer's Investment Research
Jun-18-19,Cancer Therapy Stocks Soar After Pfizer Deal,Investopedia
Jun-18-19,Shares of cancer-therapy companies skyrocket after Pfizer acquisition news,MarketWatch
Jun-19-19,"This would be the worst-case scenario for health companies, according to UBS",MarketWatch
Jun-19-19,Cancer/Gene Therapy Biotechs in Focus After Pfizer-Array Deal,Zacks
Jun-19-19,Merck's Keytruda Gets 2nd Label Expansion Approval in June,Zacks
Jun-19-19,2 Midcaps to Watch Should Pfizer-Array Deal Spark M&A Fever in Biotech Land,TheStreet.com
Jun-20-19,"The Zacks Analyst Blog Highlights: Incyte, Blueprint Medicines, Verastem and uniQure",Zacks
Jun-20-19,"This would be the worst-case scenario for health stocks, according to UBS",MarketWatch
Jun-21-19,"This would be the worst-case scenario for health stocks, according to UBS",MarketWatch
